For press enquiries, please email email@example.comPress kit
From the press
New partnership to accelerate understanding of genetics of Long COVID and help identify new treatments
A new partnership between PrecisionLife and Sano Genetics will help advance researchers’ understanding of the drivers of Long COVID, identifying at-risk patients and potential drug targets.
11 May 2022
Fatty Liver Disease: Fight against ‘Silent Epidemic’ boosted by genetic testing and lifestyle support for at-risk Americans
New collaboration offers free DNA Testing for Americans at risk of, and living with, NAFLD/NASH
25 Apr 2022
Sano Genetics raises $11M in funding to accelerate genetic disease research
We are excited to announce our Series A funding round led by MMC Ventures.
28 Mar 2022
Scientists call for 3,000 UK Long COVID sufferers of all ages, genders and ethnicities to help probe genetic link
Scientists hope to advance research and explore the relationship between genetics and an individual’s reaction to the virus with a more diverse sample of genetic data.
01 Sep 2021
Think tank publishes assessment of Sano’s digital platform for patient experience led research
The new report from PHG Foundation identifies the potential for unprecedented opportunities to enrich existing datasets.
20 Apr 2021
Sano's COO and Co-founder featured in DNA Weekly
Check out Charlotte's interview on how Sano is changing the future of research participation.
24 Mar 2021
Genetics of Long COVID study featured on BBC News
Our at-home DNA testing study was showcased on BBC Look East (West) and BBC News online.
23 Mar 2021
Sano Genetics partners with BenevolentAI & C4X Discovery to power precision medicine in Inflammatory Bowel Disease
A new collaboration between Sano Genetics and industry partners aims to accelerate drug and biomarker discovery in ulcerative colitis (UC), a form of Inflammatory Bowel Disease (IBD).
03 Feb 2021
Sano Genetics accelerates research into Long Covid after raising £2.5M ($3.2M) in seed funding
The new funding is led by Episode1 Ventures, alongside Seedcamp, Cambridge Enterprise, January Ventures, and several UK, Europe, and US-based angel investors.
25 Jan 2021
Long-COVID study featured on Channel 4 news
Our at-home DNA testing study was showcased on national television.
16 Oct 2020
UK Leading On Patient-Centric Precision Medicine Research
A novel system which will allow rare disease patients and their caregivers to add additional information about themselves to research databases is being developed by Sano Genetics in collaboration with Zetta Genomics and Genomics England.
27 May 2020
Sano Genetics and Lifebit Partnership
Sano Genetics Deploys Lifebit CloudOS, Delivers Free Genotype Imputation for Direct to Consumer (DTC) Genetics Customers. By democratising access to data securely, Lifebit and Sano empower data-driven insights for DTC customers and life sciences researchers.
09 Jan 2020
Genomelink and Sano Genetics Partnership
The biotech startup, Genomelink, has announced it is partnering with genomic research and data-sharing startup, Sano Genetics, that will match consumers’ genetic information with new medical research. The aim of this partnership is to encourage more consumers to donate their DNA for research and to be rewarded in return.
03 Oct 2019
About Sano Genetics
At Sano, we believe in a future where medicine is personalised to you, and we need your help to build it.
Data privacy and transparency are at the heart of everything we do, so users own and control all of their data. No information is ever shared without asking for consent first.More